IRONWOOD PHARMACEUTICALS INC — Director's Dealing 2021

May 26, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRONWOOD PHARMACEUTICALS INC (IRWD)
CIK: 0001446847
Period of Report: 2021-05-24

Reporting Person: MCCOURT Thomas A (President and Interim CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-24	Class A Common Stock	S	1716	$12.25	Disposed	566499	Direct

Footnotes

F1: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on May 1, 2019.